Showing results (151-160 of 237) with videos related to

Sort By:
Pageof 24
Advances in Radiation Oncology|July 26, 2017
Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapyAyobami Ajayi, Wei-Ting Hwang, Neha Vapiwala, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomyBrian C Baumann, Thomas J Guzzo, Jiwei He, et al.
Geohealth|June 8, 2026
Pediatric Risk Mapping From Co-Exposure to Extreme Temperatures and Air PollutantsJagadeesh Puvvula, Jonathan J Szeto, Jabeen Taiba, et al.
Clinical Lung Cancer|July 14, 2023
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimensWilliam P Tompkins, Wei-Ting Hwang, Yu-Xiao Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanomaXiaowei Xu, Lianjun Chen, DuPont Guerry, et al.
Lung Cancer (Amsterdam, Netherlands)|November 5, 2019
Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracyJeffrey C Thompson, Wei-Ting Hwang, Christiana Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|March 30, 2016
Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder CancerBrian C Baumann, Jiwei He, Wei-Ting Hwang, et al.
Cancer|January 7, 2014
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710John P Christodouleas, Brian C Baumann, Jiwei He, et al.
The Journal of Biological Chemistry|April 3, 2012
Lin-28 homologue A (LIN28A) promotes cell cycle progression via regulation of cyclin-dependent kinase 2 (CDK2), cyclin D1 (CCND1), and cell division cycle 25 homolog A (CDC25A) expression in cancerNing Li, Xiaomin Zhong, Xiaojuan Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2022
Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy StudiesYimei Li, Wei-Ting Hwang, Shannon L Maude, et al.
Pageof 24